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Purpose: Managed care whether through risk or through capitated contracts re ults in 
reduction in resources, reduced length of hospital stay, and reduced utilization of hos- 
pital resources (collectively referred to as resource reductions). These resource reductions 
become ven more noticeable as a greater proportion of Medicare patients who need 
vascular operations elect a managed-care s nior product. We examined the results of a 
4-year experience with resource management in an academic vascular surgery practice 
during which best practice plans were developed and implemented. 
Methods: We analyzed hospital cost data, which included both total hospital and intensive 
care unit length of stay, average units per operation for laboratory, pharmacy, and radi- 
ology services and operating room and direct hospital costs for 257 carotid endarterec- 
tomies performed over fiscal years (BY) 1994, 1995, 1996, and 1997 (6 month data) and 
175 infrainguinal bypass procedures performed uring the same period. 
Results: For carotid endarterectomy, length of stay decreased 66% over the 4-year peri- 
od to an average of 2.07 days in BY97. Both radiology and pharmacy utilization were 
reduced after the first year of institution of best practice plans (56% and 32% respec- 
tively) with 4-year total reductions of 86% and 55% by FY97. The most notable changes 
included elimination of routine postoperative laboratory testing, use of aspirin rather 
than low-molecular-weight dextran, emphasis on oral rather than intravenous vasoactive 
drugs, and routine use of duplex scanning alone rather than angiography for diagnosis 
after BY94-95. The length of operating room time for carotid endarterectomy remained 
relatively constant from FY94 to FY97. As a result of these multiple factors, our study 
showed a 30% decrease in total average direct hospital costs for carotid endarterectomy 
from $9974 to $7002 in this 4-year period. Infrainguinal bypass graft procedures 
showed a progressive decrease in total cost of 28% for patients without complications to 
$15,186 but remained unchanged for those with complications. Laboratory use, phar- 
macy use, and radiology use were not significantly different. 
Conclusions: Case management for patients undergoing carotid endarterectomy and 
infrainguinal bypass grafting involving an integrated team of vascular surgeons, surgical 
house staff, a dedicated vascular nurse, and a social work case manager resulted in dra- 
matic reductions both in length of stay and hospital resource utilization. As these costs 
decreased, operating room expenses assumed increasing importance. Operating room 
costs account for 60% of the direct costs of carotid endarterectomy and a comparable 
percentage for uncomplicated infrainguinal bypass grafting. Further substantial reduc- 
tions in direct hospital costs will depend primarily on reductions in operating room 
costs, particularly those related to length of time in the operating room. (J Vase Surg 
1998;27:1066-77.) 
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Managed care whether through risk or through 
capitated contracts re ults in reduction in resources, 
reduced length of hospital stay, and reduced utiliza- 
tion of hospital resources (collectively referred to as 
resource reductions). These resource reductions will 
become even more imperative as a greater propor- 
tion of  Medicare patients who need vascular opera- 
tions selects a managed-care s nior product. Tertiary 
care centers with large referral bases for complex 
operations and reoperations will suffer most if costs 
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are not contained. A hospital study conducted in 
1985 and 1986 among three Boston academic med- 
ical centers showed a wide variability in use of 
resources for carotid endarterectomy and infrain- 
guinal bypass grafting. Length of stay for infrain- 
guinal bypass averaged 22 days, and extensive labo- 
ratory studies were the norm. The implication of 
that  study was to take the best practice (lowest 
resource utilization) that combined the manage- 
ment components from these three institutions into 
one overall strategy to guide patients through ahos- 
pitalization for a vascular procedure. A best practice 
plan that evolved in 1989 through 1993 was com- 
bined with case management i  mid 1994, and this 
strategy ensured both quality assurance and cost 
effectiveness among patients undergoing carotid 
endarterectomy and peripheral rterial bypass opera- 
tions. Calligaro et al. 1 successfully implemented a 
10-step strategy that decreased hospital costs for 
patients undergoing vascular operations. 
Length of hospital stay has been the dominant 
factor driving hospital costs, so a reduction of hospi- 
tal resources by decreasing time in the hospital is an 
important starting point. 2Length of stay already has 
been found important in femoropoplitcal rterial 
reconstruction a d carotid endarterectomy. 3-s Early 
discharge after carotid endarterectomy now is 
accepted as a safe and realistic option. 6-9 It has been 
well established that a diagnosis-related group does 
not compensate for hospital resource utilization, 
especially in vascular operations when limb salvage is 
involvedJ 0Negative margins result unless the cost of 
treatment is reduced. The answer to cost contain- 
ment beyond reduction in length of stay lies in care- 
fully selected utilization of resources aimed at main- 
taining, and optimally improving, quality of out- 
comes. We examined our 4-year experience with 
resource reduction in two of the most common 
peripheral vascular procedures--carotid endarterec- 
tomy and infrainguinal bypass. Using fiscal year 1994 
(FY94) as a baseline period in which practices were 
not standardized and no protocols were implement- 
ed, we analyzed the effects of sequential changes 
instituted at the end of FY94 on the next three fiscal 
years with regard to reduction of hospital costs. 
METHODS 
The medical records of all patients admitted to 
New England Medical Center (NEMC) between 
October 1993 and March 1997 who underwent 
either carotid endarterectomy or infrainguinal rter- 
ial bypass procedures were reviewed retrospectively. 
The records were analyzed by each fiscal year, which 
begins on Octobcr 1. Fiscal year 1997 included ata 
for the first 6 months. Patients who underwent com- 
bined procedures, uch as carotid endarterectomy 
with coronary artery bypass grafting or aorto- 
femoral-femoropopliteal bypasses in one hospital- 
ization were excluded. Carotid operations were 
performed with general anesthesia nd selective 
shunting on the basis of electroencephalographic 
(EEG) criteria. Infrainguinal operations were per- 
formed with general or regional anesthesia. 11 
Records were assessed for total ength of stay, length 
of stay in an intensive care unit (ICU), and duration 
of operative procedure. 
The accounting department prospectively col- 
lected hospital costs at NEMC. The data for room 
and board, inpatient radiologic examinations, labo- 
ratory testing, pharmacy services, operating room 
use, and blood bank services were totaled. Statistical 
analysis of financial data according to fiscal year was 
provided by the center for clinical research at 
NEMC. The Kruskal-Wallis test with ranks was used 
to compare medians of costs or length of stay 
between the 4 fiscal years or between groups with 
complications and those without complications. 
Linear regression was used to analyze the 
remaining nonfinancial data between years for trend. 
Statistical significance was assumed if the p value was 
<0.05. Subgroup analysis was performed with 
Bonferroni adjusted p values from pairwise compar- 
isons of medians (_<0.05). Complication rates were 
further analyzed with a Fisher exact test in which 
cvent rates were compared between the 4 fiscal 
years. The Cochran-Armitage tr nd test was used to 
look for trends in complication rates and was 
assumed positive for a p value <0.05. We then exam- 
ined the relation between complications and total 
cost using linear egression analysis to build a model 
of log e (total cost). We used a stepwise selection 
process, with model entry and removal p values of 
0.15, to choose which complications (bleeding, 
wound infection, graft failure, and limb loss) should 
be in the cost model. A second linear regression 
model for log e (total cost) was constructed. This 
model included the complications previously select- 
ed and stepwise regression together with fiscal year 
as a linear term to adjust for cost differences over 
time. 
Complications for this group were defined as 
graft failure, limb loss, wound infection, bleeding, 
cardiac problems, and pulmonary problems. Graft 
failure was labeled as thrombosis of the graft either 
in the hospital or in follow-up office evaluation with- 
in the first 30 days of the operation. Limb loss was 
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Table I. Financial data for carotid endarterectomy fiscal years 1994-1997 at New England Medical Center 
Fiscal year Fiscal year Fiscal year Fiscal year 94 vs 94 vs 94 vs 95 vs 95 vs 96 vs 
Variable 1994 (n = 49) 1995 (n = 91) 1996 (n = 71) 1997 (n = 45) p Value* 95 96 97 96 97 97 
Length 6.08 +_ 0.67 3.93 -+ 0.38 3.38 ± 0.35 2.07 _+ 0.27 0.0001 y y y - -  y y 
o f  stay (d) 
Pharmacy $616.00 $416.90 $377.51 $278.20 0.0001 y y y - -  y - -  
cost +- 50.91 _+ 37.07 -+ 30.70 -+ 16.16 
Radiology $880.39 $390.62 $292.90 $121.56 0.0001 y y y - -  y - -  
cost -+ 122.14 -+ 70.02 -+ 72.43 -+ 46.50 
Operating $4309.31 $4394.45 $3828.50 $4086.91 0.0328 - -  - -  - -  y - -  - -  
room cost ± 149.05 _+ 137.82 ± 140.80 ± 148.33 
Room cost $3433.27 $2677.96 $3078.06 $1761.51 0.0001 y - -  - -  y - -  y 
-+ 612.15 • 391.46 ± 368.29 ± 175.81 
$9974.33 $8591.08 $8481.32 $7002.07 0.0026 y y y - -  - -  - -  
± 860.24 • 575.34 ± 574.64 -+ 301.82 
3.76 3.44 3.52 3.02 0.0002 - -  - -  y - -  y y 
-+ 0.12 + 0.10 +- 0.13 +- 0.08 
Total cost 
Operating 
room time (Jar) 
Yearly averages for 257  carotid endarterectomies with pairwise comparisons to determine year to year significance. 
*p Value f rom Kruskal-Wallis test (a nonparametr ic  test with ranks to compare  mcdians between the four fiscal years). 
y, Bonferroni adjusted p value from pairwise comparisons of medians (p < 0.05). 
defined as amputation either below or above the 
knee within the first 30 days after the operation. 
Bleeding was defined as blood loss necessitating 
operative intervention. Wound infection was defined 
as clinical and physical findings in any incision that 
necessitated intravenous administration of antibi- 
otics, d4bridement, or drainage of purulence. 
Cardiac events (myocardial infarction) were defined 
as elevation of serial cardiac enzymes with or with- 
out electrocardiographic changes. Pulmonary events 
were defined aspresence of pneumonia necessitating 
intravenous administration of antibiotics. 
The practice plans of the vascular group at 
NEMC were altered to implement optimal resource 
management ear the end of FY94, so FY94 is used 
as the base year for comparisons. Aspirin replaced 
the more expensive drug, low-molecular-weight 
dextran, in the perioperative period as an antiplatelet 
agent and emphasis was placed on oral rather than 
intravenous administration of vasoactive drugs to 
decrease pharmacy costs. We also implemented a 
shift from arteriography to duplex ultrasonography 
in extracranial carotid operations. Duplex evaluation 
of the carotid artery was safe and reliable when com- 
pared with conventional preoperative arteri- 
ography. 12 Other authors have found this strategy 
reliable.13,14 Extracranial carotid duplex imaging 
was reimbursed at NEMC $108,35 for the technical 
component and $37.20 for the professional compo- 
nent by the Medicare allowable fee schedule in 
FY97. Arteriography, which was more expensive, 
was reserved for complex cases or those involving 
the upper extremity (e.g., subclavian steal syn- 
drome). This also avoided the 1.2% stroke risk asso- 
ciated with cerebral arteriography demonstrated in 
the Asymptomatic Carotid Artery Stcnosis study. 15 
There also was a conversion from inpatient o out- 
patient imaging in preoperative planning for periph- 
eral bypass procedures. 
Communication between patients (with their 
families) and surgeons (with the nurse coordinator) 
was essential in preoperative planning, expectations 
for length of stay, and selection of diagnostic and 
therapeutic options. Designation of an expected 
1-day length of stay for carotid endarterectomy and 
5-day length of stay for infrainguinal bypass grafting 
was conveyed to the patient before the operation 
and reemphasized to the family. A case manager 
assessed discharge planning before the operation and 
monitored progress throughout the stay according 
to accepted guideposts. The protocol is summarized 
in Fig. 1. Laboratory costs were kept to a minimum. 
Patients who underwent carotid endarterectomy or 
peripheral arterial bypass underwent observation 
immediately after the operation in an intermediate 
care facility on a dedicated vascular ward so that 
ICU use was minimized. All patients are admitted to 
the hospital the same day as the operation whenever 
possible. 
RESULTS 
Two hundred fifty-seven carotid endarterec- 
tomies were performed at NEMC in the study peri- 
od; this figure encompassed both urgent and elective 
operations. M1 operations were performed by an 
attending vascular surgeon and either a vascular 
surgery fellow or senior surgical resident. Table I 
summarizes the carotid endarterectomy data. The 
mean length of hospital stay decreased by 66% from 
6.08 _+ 0.67 days in FY94 to 2.07 + 0.27 days in 
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Case Management Flow Chart 
Pre-Admission (Attending MD, Case Manager RN, Clinic RN) 
Identify the Continuing Care Needs of Pre-Operative Patients 
Based upon: 
*Age 
*Family Supports 
*Insurance Type 
Discharge Options: 
*Home 
*Home Care/VNA 
*Rehab Placement - Transitional Care Unit 
Post-operative Day 1 ( Resident MD and Case Manager RN) 
Discuss Outcome of Surgical Procedure and Patient Needs 
*CEA Patient - D/C Home 
*BPG Patient - Initiate planned referral to Home Care/VNA 
*BPG Patient - Initiate planned referral to Subacute Rehab 
Post - Discharge Day 1 (Clinic RN) 
Evaluate Case Management Plan 
*CEA Patient - Home Phone Call 
*BPG Patient - Home Phone Call 
*BPG Patient - Rehab Phone Call 
Out- Patient Clinic Visit (Attending MD and Clinic RN) 
Further Evaluate Case Management Plan 
Fig. 1. Protocol for case management. 
FY97 (p < 0.0001). The ICU was used selectively 
during the entire study period such that only 54 
patients (21%) in the carotid group and 33 patients 
(19%) in the bypass group spent one or more days 
receiving intensive care. 16 
Monitoring the night immediately after the 
operation underwent a transition in 1995. At the 
beginning of the study, patients routinely stayed in 
the recovery room the night after the operation with 
a variable cost of $1585.20 for a 24-hour period 
(similar to an ICU setting). Beginning in June 1995, 
patients were placed in an intermediate care unit on 
a dedicated vascular ward with a variable cost of 
$440.86 for a 24-hour period. 
Use of same-day admission underwent a statisti- 
cally significant three-fold increase from 22% 
(11/48) in FY94 to 62% (56/91) in FY95 and 78% 
(35/45) in FY97 (p < 0.001). Because of this prac- 
rice and the decrease in length of stay, room costs 
fell from $3433.27 _+ 612.15 in FY94 to $1761.51 
± 175.81 in FY97 (p < 0.0001). Average pharmacy 
costs decreased from $616.00 _+ 50.91 to $278.20 ± 
16.16 (p < 0.0001), and inpatient radiology costs 
fell from an average of $880.39 _+ 122.14 to 
$121.56 ± 46.50 (p < 0.0001) with the change in 
late 1994 from use of arteriography to use of duplex 
ultrasound evaluation. The number of arteriograms 
performed before carotid endarterectomy decreased 
significantly from 88% (43/49) in FY94 to 11% 
(5/45) in FY97. The total hospital cost for carotid 
endarterectomy averaged $9974.33 -2_ 860.24 in 
FY94 and fell 30% to $7002.07 ± 301.82 in F¥97 
(p < 0.003). Basic to all calculations was the rate of 
inflation, which would mal~e these differences even 
more impressive. Though time in the operating 
room fell from 3.76 ± 0.12 hours to 3.02 ± 0.08 
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Table I I .  Financial data for infrainguinal bypass operations fiscal years 1994-1997 at New England 
Medical Center 
Variable Fiscal year 1994 Fiscal year 1995 Fiscal year 1996 Fiscal year 1997 p Value* 
Total cost $20732.58 • 1649.18 $16312.46 • 886.50 $16607.78 • 1492.88 $21801.00 • 3697.10 0.08 
Total cost with $19431.78 • 2773.80 $19951.77 • 0.67 $20028.64 ± 0.67 $26211.33 • 5488.56 0.87 
complications 
Total cost without $21032.77 • 1937.47 $15366.24 • 0.67 $15617.53 • 0.67 $15185.50 • 2965.38 0.034 
complications 
Length of 12.00 • 1.35 8.54 • 0.69 9.12 • 0.94 10.87 ± 1.97 0.18 
stay (d) 
Length of 9.56 • 2.00 10.54 • 0.67 10.72 ± 0.67 12.67 • 2.80 0.72 
stay with 
complications (d) 
Length of 12.56 • 1.59 8.02 • 0.67 8.66 • 0.67 8.17 • 2.44 0.04 
stay without 
complications (d) 
Length of 0.02 • 0.02 0.02 ± 0.02 1.14 ± 0.46 1.67 • 0.91 0.001 
stay in intensive 
care unit (d) 
Pharmacy cost $1580.44 • 206.6i $991.94 • i19.48 $1195.47 • 159.41 $2315.93 • 975.41 0.06 
Radiology cost $1662.58 ± 222.33 $1017.25 • i38 32 $833.31 • 141.75 $1171.27 • 304.77 0.046 
Operating $5963.96 ± 288.14 $5751.83 ± 190.06 $4667.71 ± 219.47 $6498.07 ± 491.64 0.004 
room cost 
Operating 6.60 • 0.37 5.81 • 0.25 6.04 • 0.27 6.91 • 0.61 0.54 
room time (hr) 
Room cost $10574.08 • 1158.97 $7824.81 • 629.98 $7995.49 • 955.67 $8892.87 • 2024.89 0.22 
Yearly averages for 175 infrainguinal bypass operations. 
*p Value from Kruskal-Wallis test (a nonparametric test with ranks to 
hours (p < 0.0002), operating room costs remained 
about the same, averaging $4309.31 _+ 149.05 in 
FY94 and $4086.91 + 148.33 in FY97. 
One hundred seventy-five peripheral arterial 
infrainguinal bypass procedures performed at NEMC 
in the study period. Table I I  summarizes the infrain- 
guinal artery bypass data. Same-day admissions dou- 
bled from 23% (11 /48)  in FY94 to 53% (8 /15)  in 
FY97 (p = 0.0007).  The number  o f  arteriograms 
obtained during the same admission as the bypass 
procedure decreased significantly from 65% (31 /48)  
in FY94 to 40% (6 /15)  in 1997 (p = 0.0087).  
Length of  stay was 12.00 ± 1.35 days in FY94 and 
10.87 ± 1.97 days in FY97 (p = 0.18) and total cost 
was $20,732.58 ± 1649.18 and $21,801.00 ± 
3697.10 (p = 0.08) respectively, both o f  which lacked 
statistical significance. No  statistical difference was 
found in the total cost o f  care o f  patients undergoing 
reoperations or operations in patients transferred 
from other hospitals compared with care o f  patients 
undergoing a first bypass procedure (p = 0.32). 
Complications for carotid endarterectomy did 
not  change throughout  the study period when ana- 
lyzed with a Fisher exact test (p = 0.32) and are list- 
ed in Table I I I .  There were no deaths and there were 
four strokes among 257 operations, there was no 
difference in i cidence of  stroke between fiscal years. 
One stroke occurred in FY94 and three in FY96. 
compare medians between the four fiscal years). 
This gives a combined stroke-death rate o f  1.56%. 
One transient ischemic attack with no residual 
deficit occurred in FY94, one myocardial infarction 
in FY95, and two reoperations for hematoma evacu- 
ation in FY97. 
Individual complicat ion rates for infrainguinal 
bypass were unchanged between FY94 and FY97, 
but a significant increase was seen from FY94 to 
FY97 (Fisher's exact test p -- 0.008; Table I I I ) .  
Patients undergoing reoperations or operations after 
transfer from other hospitals had a higher incidence 
o f  complications; thus their proport ion defined the 
overall volume o f  complications. The increase in 
complications among patients undergoing bypass in 
FY97 appeared to be caused by the nearly twofold 
increase in number  o f  complex reoperations and 
operations in transferred patients from an average o f  
25.8% in FY94 through FY96 to 46.7% in 1997. The 
early graft failure rate averaged 8.5 7% (15 /175)  and 
was comparable with rates in the literature.17,18 The 
rate o f  readmission within 30 days o f  discharge aver- 
aged 17.7% (31 /175)  in the study period with no 
statistical difference between years (p = 0.49). 
A study we performed in 1986 showed the pow- 
erful influence o f  complications on length of  stay 
and resource utilization. Therefore we subdivided 
the infrainguinal bypass population into those with 
and those wi thout  complications. When data on 
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Tab le  I I I .  Compl icat ion  rates per fiscal year for carotid and  infra inguinal  bypass operat ions at New 
Eng land  Medical  Center  
p Value test 
Complication Number Percentage FY94 FY95 FY96 FT97 Overall p Value* for trendy 
Carotid operations 
(n = 257) 
Deaths 0 0.00 0 0 0 0 
Strokes 4 1.56 1 0 3 0 
Transient ischemic 1 0.39 1 0 0 0 
attack without 
deficit at discharge 
MI 1 0.39 0 1 0 0 
Reoperations for 2 0.78 0 0 0 2 
hematoma 
Rate of one or - -  - -  6 1 4 7 
more complications (%) 
Bypass operations 
(n = 175) 
Deaths 1 0.57 0 0 0 1 
Limb loss 4 2.29 1 0 1 2 
Graft failure 15 8.57 7 2 2 4 
Bleeding 5 2.86 1 1 2 1 
Wound infection 16 9.14 2 7 5 3 
Pulmonary 2 1.14 0 0 1 1 
(pneumonia) 
Rate of one or - -  - -  19 21 22 60 
more complications (%) 
0.32 (*f) 0.6 
0.008 (*c) 0.001 
*c, p Value from chi-square test comparing event rates between the four fiscal years. 
*f,, p Value from Fisher exact est comparing event rates between the four fiscal years. 
?p Value from Cochran-Armitage Trend Test _<0.05. 
Tab le  IV. F inancial  data for fiscal years 
1994-1997 at New Eng land  Medical  Center  
Variable Value 
Total cost with other $21201.81 
complications 
Total cost with no other $17091.50 
complications 
LOS with complications (d) 10.83 
LOS without complications (d) 9.54 
Total cost for LL or GF $23106.58 
with complications 
Total cost for LL or GF $17465.51 
without complications 
LOS for LL or GF with 11.37 
other complications (d) 
LOS for LL or GF with no 9.67 
other complications (d) 
Total cost with no $17091.50 
complications 
Total cost with one $20187.41 
complication 
Total cost with two or $28708.18 
more complications 
LOS with no complications (d) 9.54 
LOS with one complication (d) 10.32 
LOS with two or more 14.60 
complications (d) 
Total cost by claudication $13111.19 
Total cost by rest pain $17735.49 
Total cost by tissue loss $21069.93 
_+ 1548.78 
±876.79 
• 0.97 
_+ 0.66 
-+ 2852.61 
+ 783.52 
-+ 1.59 
+ 0.59 
+876.79 
+ 1289.46 
± 8933.18 
± 0.66 
-+ 0.94 
± 4.33 
+915.92 
±1308.59 
±1308.11 
Four year averages forinfrainguinal bypass operations. 
LL, Limb loss; GF, graft failure; LOS, length of stay. 
patients with one or more  compl icat ions were com-  
pared with those on  pat ients w i thout  compl icat ions,  
several s ign i f icant  results  were found.  Tota l  cost  
among pat ients  w i thout  compl i ca t ions  (n = 133,  
76%) fell f rom $21,032 .77  + 1937.47  in IzY94 to 
$15 ,185 .50  x 2965.38  in FY97 (p < 0.034).  Total  
costs among pat ients wi th  compl icat ions (n = 42)  
were not  s igni f icant ly  d i f ferent  ($19 ,431 .78  x 
2773.80  in FY94 vs $26 ,211 .33  ± 5488.56  in FY97; 
p = 0.87) .  
Four-year  summary  data are detai led in Tables 
IV  and V. The  total cost o f  care o f  pat ients w i thout  
compl icat ions over the 4-year study per iod averaged 
$17 ,091 .50  + 876.79 ,  and  the cost o f  care o f  
pat ients wi th  compl icat ions averaged $21 ,201 .81  +_ 
1548.78 (p < 0.003) .  Reduct ion  o f  length  o f  stay 
between FY94 and FY97 among pat ients  w i thout  
compl icat ions (n = 133) bordered  on  signif icance 
(12.56 + 1.59 days in 1994 vs 8.17 + 2.44 days in 
1997;  p = 0.06).  Length  o f  stay among patients with 
compl icat ions (n = 42)  showed no  signif icant change 
(9.56 _+ 2.00 days in 1994 vs 12.67 ± 2.80 days in 
1997;  p = 0.72) .  Length  o f  stay among pat ients  
w i thout  compl icat ions over the 4-year study per iod 
averaged 9 .54 _+ 0.66 days, and that  among patients 
with compl icat ions averaged 10.83 _+ 0.97 days (p < 
0.04).  The  presence o f  either l imb loss or  early graft 
JOURNAL OF VASCULAR SURGERY 
1072 Roddy et al. June 1998 
Tab le  V. Patient data 
Variables Fiscal year 94 Fiscal year 95 Fiscal year 96 Fiscal year 97 Overall total p Value* 
Bypass grafts 
Total number of patients 48 (100.00) 63 (100.00) 49 (100.00) 15 (100.00) 175 (100.00) 
Same-day admission--yes 11 (22.92) 21 (33.33) 28 (57.14) 8 (53.33) 68 (38.86) 0.0007 
Same-day admission--no 37 (77.08) 42 (66.67) 21 (42.86) 7 (46.67) 107 (61.14) 
Reoperative/transfer case--yes 13(27.08) 15 (23.81) 13 (26.53) 7 (46.67) 48 (27.43) 0.32 
Reoperative/transfer case--no 35 (72.92) 48 (76.19) 36 (73.47) 8 (53.33) 127 (72.57) 
Angiogram during this admission 31 (64.58) 27 (42.86) 17 (34.69) 6 (40.00) 81 (46.29) 
Angiogram not on this admission 17 (35.42) 36 (57.14) 32 (65.31) 9 (60.00) 94 (53.71) 0.0087 
Indication--claudication 15 (31.25) 14 (22.22) 9 (18.37) 4 (26.67) 42 (24.00) 
Indication--rest pain 11 (22.92) 20 (31.75) 20 (20.00) 6 (40.00) 57 (32.57) 
Indication--tissue loss 21 (43.75) 29 (46.03) 20 (40.82) 4 (26.67) 74 (42.29) 
Indication--rest pain and 32 (66.67) 49 (77.78) 40 (60.82) 10 (66.67) 131 (74.86) 0.37 
tissue loss 
Indication--popliteal aneurysm 1 (2.08) 0 (0.00) 0 (0.00) 1 (6.67) 2 (1.14) 
30-day associated minor 7 (14.58) 9 (14.29) 6 (12.24) 2 (13.33) 24 (13.71) 
amputation ratC 
30-day readmission rate 5 (10.42) 15 (23.81) 8 (16.33) 3 (20.00) 31 (70.71) 
Carotid patient data 
Total number of patients 49 (100.00) 91 (100.00) 72 (100.00) 45 (100.00) 257(100.00) 
Preoperative carotid angiogram 43 (87.76) 15 (16.48) 14 (19.44) 5 (11.11) 77 (29.96) 
Same-day admission--yes 11 (22.45) 56 (61.54) 47 (65.28) 35 (77.78) 149 (57.98) 0.0001 
Same-day admission--no 37 (75.51) 35 (38.46) 25 (34.72) 10 (22.22) 107 (41.63) 
Values are numbers of patients with percentages in parentheses. 
*p Value from Wald chi-square t st of the linear effect of fiscal year on the outcome of a logistic regression 
Hncludes toe and transmetatarsal amputations only. 
model. 
failure significantly increased total cost f rom 
$17,465.51 _+ 783.52 to $23,106.58 -+ 2852.61 (p = 
0.023) but did not  increase length of  stay (9.67 __. 
0.59 days vs 11.37 _+ 1.59 days; p = 0.16). This dis- 
parity was probably related to reuse of  the operating 
room for graft failure, bleeding, and, in some 
instances, wound ddbridement, which wc believe to 
have a concomitant  amplifying effect on resource 
use. When number  o f  complications was analyzed, 
total cost increased f rom $17,091.50 _+ 876.79 
with no complications (n = 133) to $20,187.41 +_ 
1289.46 with one compl icat ion (n = 37) to 
$28,708.40 _+ 8933.18 with two or more complica- 
tions (n = 5) (p < 0.01). 
In a cost analysis according to indication (Table 
VI),  patients with claudication (n = 42) had a total 
cost o f  $13,111.19 _+ 915.92, those with rest pain 
(n = 57) $17,735.49 _+ 1308.59,  and those with 
tissue loss (n = 74) $21,069.93 _+ 1308.11.  
Compar ison by means of  linear rcgrcssion of  total 
cost according to indication revealed no significant 
dif ference between rest pain and tissue loss (p = 
0.10). Rest pain and tissue loss were both signifi- 
candy different from claudication (p = 0.0027 and 
p = 0.0001, respectively). 
For evaluation o f  the trends f rom year to year, a 
pre l iminary stepwise regression mode l  was con- 
structed with the log o f  total cost for a more normal 
distribution for infrainguinal opcrations. With this 
model ,  a correlat ion was found in both  year and 
complication variability. A total cost decrease of  9% 
was identified per year, and a total cost increase o f  
28% was identified per complication. 
Whenever  length o f  stay was decreased after 
major vascular procedures, concern arose over shift- 
ing of  cost f rom the inpatient o the outpatient set- 
ting. Subacute rehabilitation facilities were defined as 
centers that provided sldlled nursing services on a 
daily basis. Acute rehabilitation facilities wcrc defined 
as centers that provided sldlled nursing services and 
at least two goal-oriented therapies on a daily basis 
(physical, occupational, speech, and inhalation). In 
our  series, 4% of  the patients in the carotid 
endarterectomy group went to a subacute rehabilita- 
tion facility and none to an acute rehabilitation facil- 
ity. This had to do with the inherent nature of  carotid 
operations. Only 38% of  the patients who underwent 
bypass procedures were discharged to rehabilitation 
facilities. For this subset, 73% went to subacute facil- 
ities and 26% to acute facilities. 
An added factor was considered in our  team 
approach. This related to the cost o f  a dedicated vas- 
cular nurse and case worker. The vascular nurse posi- 
t ion had been present at NEMC for many years, and 
salary averaged 80% from general surgery and 20% 
from vascular surgery. At the end of  FY94, the job 
descript ion was altered to 80% vascular and 20% 
general surgery. This redefinition cost the vascular 
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Table VI. Total cost of indication 
Indication Fiscal year 1994 Fiscal year 1995 Fiscal year 1996 Fiscal year 1997 Overall 
Claudication $14280.67 $12951.43 $12110.56 $11536.25 $13111.19 
_+ 1439.01 _+ 1406.62 _+ 2864.60 _+ 1615.70 _+ 2283.82 
Rest pain $17535.82 $15964.35 $18471.60 $211551.67 $17735.49 
.+ 2283.82 ± 1404.18 _+ 2926.36 _+ 4924.25 ± 1308.59 
Tissue loss $27549.48 $18175.10 $16757.70 $29551.00 $21069.93 
_+ 2798.31 ± 1446.54 _+ 1745.06 ± 10472.30 ± 1308.12" 
*Comparison by linear regression of  the log (total cost) between indications reveals no difference (p = 0.1023) between rest pain and 
tissue loss. 
There is a significantly increased cost between claudication and both tissue loss (p = 0.0001) and rest pain (p = 0.0027). 
department approximately $41,000. The case man- 
ager was not present before the end of FY94. After 
she joined the team, she devoted 40% of her time to 
vascular issues. This was at a cost to the hospital of 
nearly $25,000. 
DISCUSSION 
Our study demonstrated that on our vascular 
unit the total cost for carotid endarterectomy was 
lowered significantly by one third over the course of 
the 3.5-year study period (p < 0.003). This cost 
reduction was the result of progressive changes in 
the practice plans of our service. A comprehensive 
patient care plan to decrease hospital costs was insti- 
tuted early in the study period. It facilitated com- 
munication between patients, families, hospital staff, 
and surgeons and avoided use of unnecessary 
resources. Hoyle et al.9 demonstrated the effect of 
the services of a case manager in decreasing cost 
while maintaining quality. This was apparent in our 
study with the clear reduction in length of stay and 
costs after 1994 for both carotid endarterectomy 
and bypass operations without complications. 
Dardik et al. 19 presented the Johns Hopkins 
experience with clinical pathways in carotid surgery 
with a targeted length of stay of 3 days. 
Arteriograms were performed on 198 of 201 (99%) 
patients in their preoperative evaluation. The actual 
length of stay before institution of a clinical pathway 
was 8.32 days during which patients pent 2.2 days 
in the hospital before the operation. After the oper- 
ation patients tayed in the ICU for 1.4 days and in 
the hospital for 6.0 days. The 87% of patients who 
finished the critical pathway averaged a length of 
stay of 3.6 days with 0.9 days in the hospital before 
the operation and a postoperative hospital stay of2.8 
days (with 1.0 clays in the ICU). By contrast, the 
goal of our pathway was similar to that proposed by 
Luna and Aydc, 4 Collier, 6 Kaufman et al., 7 and 
Kraiss et al.8 with same-day admission and a 1-day 
postoperative stay. Besides length of stay and use of 
an ICU, preoperative evaluation of the carotid arter- 
ies became a focus of our attention. Duplex ultra- 
sound scanning issafer, less invasive, and less expen- 
sive than angiography and has reliable results for 
operative planning. 12 Preoperative imaging has 
changed over the years from inpatient arteriography 
to outpatient duplex ultrasonography. Most of the 
diagnostic studies occur well before hospitalization 
and therefore were not included in our analysis of 
hospital cost for a given procedure given that these 
procedures are reimbursed outside the diagnosis- 
related group if they occur more than 72 hours 
before admission. 20
An experienced, vascular nurse coordinator 
worked with a discharge planner on the vascular ser- 
vice. All preoperative planning was streamlined 
through the vascular nurse, including discussions 
with patients and families. Potential problems for 
discharge were identified, and patient information 
packages were distributed and discussed thoroughly 
with the patients and their families. Expectations for 
a 1-day hospital stay after carotid endarterectomy 
were established and communicated on multiple 
occasions to patients and their families. Both nursing 
and house staff understand the goals. 
Once length of stay, ICU use, and laboratory, 
pharmacy, and radiology services have been 
addressed, further attempts at cost containment in
hospitalization for carotid endarterectomy appear to 
be in the operating room. There was no difference 
in the actual operative costs between fiscal years 
1994 and 1997 but the proportion of cost spent on 
the operating room increased from 43% in FY94 to 
58% in FY97. To limit these costs usually requires a 
decrease in actual operating room time billed. The 
following three areas can be identified as potential 
sources of cost reduction: type of anesthesia (region- 
al vs general), use of a patch, and method of cerebral 
protection. 
Regional anesthesia may have a role if the cervi- 
cal block can be administered in a holding area out- 
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side the operating room. The patient would be taken 
to the operating room and immediately placed on 
the table, prepared, and draped for the operation. 
This might eliminate the time for induction of gen- 
eral anesthesia by an attending anesthesiologist and 
would allow time for resident assistance without 
lengthening the actual time in the operating room. 
Regional anesthesia was advocated by Corson et al.21 
because when there is perioperative hypertension, it 
is of shorter duration when regional anesthesia s 
used (1.4 vs 19.6 hours in their series). Allen et al.22 
found a significantly shorter duration in the operat- 
ing room when regional techniques as opposed to 
general anesthesia were used. Perioperative anesthet- 
ic risks appear at least comparable if not less with 
regional techniques.23, 4 Regional anesthesia also 
makes EEG monitoring for cerebral protection 
unnecessary. 
The decision to use a patch also affects operating 
room time. Two suture lines take longer than one, 
and the patch adds item cost to the cost of length- 
ened operating room time. The decision for routine 
patching of all carotid arteries after endarterectomy 
may be questioned. Routine shunting increases 
operating room time marginally but does add the 
cost of the shunt. Selective shunting under general 
anesthesia requires the cost of the EEG equipment 
and the fee associated with technician operation and 
neurologist interpretation. This alone averages a
$730 hospital charge at our institution (including a
$120 physician fee). Measuring stump pressures 
adds minimally to operating room time and cost. 
Infrainguinal arterial bypass grafting for tissue 
loss or rest pain has not been as easily amenable to 
the best practice plan ashas carotid endarterectomy. 
Historically, patients with tissue loss have a longer 
length of stay and higher complication rate, espe- 
cially in regard to wound infection, and need inpa- 
tient arteriography more often than those with rest 
pain or claudication. 25 In our study the total cost of 
infrainguinal bypass operations among patients with 
rest pain was 35% greater and with tissue loss was 
61% greater than among those with claudication. We 
previously reported that 64% of our infrainguinal 
rcvascularizations are performed for tissue loss or 
gangrene. 26That figure has risen to 75%. Patients 
with tissue loss or gangrene should be considered a 
separate ntity in hospital cost analysis. 
Establishment ofour practice plan lowered total 
cost by 28% among patients without complications. 
We identified that, overall, complications increased 
total hospital costs by 24%. The presence of two or 
more complications increased hospital cost by 68%. 
A reduction in morbidity would therefore affect 
hospital cost resource utilization. The vascular unit 
at NEMC is similar to those of other tertiary care 
centers with a high proportion of reoperations and 
procedures performed for limb salvage. Overall, 
75% (131/175) of the infrainguinal bypasses per- 
formed at NEMC are for rest pain or tissue loss. 
Patients transferred directly from other hospitals or 
needing reoperations composed 27% (48/175) of 
our case load. The goal of a reduction in morbidity 
may therefore be difficult in a tertiary care center 
where these more complex procedures are per- 
formed. There also is a component of teaching res- 
idents and fellows that may not be present in a com- 
munity hospital. Patients transferred from another 
hospital typically are sicker and have longer lengths 
of stay. They have a significantly higher hospital 
costs than patients who are not transferred. Bernard 
et al.27 even  suggested that future health care costs 
and financial liability may prohibit these transfers if
additional compensation is not available. As long as 
there are academic centers that accept ransfers 
from community programs and referrals for com- 
plex reoperations, there will be a discrepancy 
among institutions. When specific aspects of mor- 
bidity are examined irectly, most wound infections 
occur over the medial aspect of the thigh incision. If 
laparoscopic or endoscopic techniques can be used 
to avoid making flaps, wound morbidity and its 
attendant cost can be decreased.28, 9 This issue had 
even greater importance in the assessment of read- 
missions, given that 62% were wound related. 
Minimally invasive techniques are being applied 
widely in the harvesting of saphenous vein for coro- 
nary artery bypass grafts. 
Hospital costs shown in this study all were 
obtained through the Transition Systems Incor- 
porated system. The Transition Systems Incor- 
porated system is proprietary software developed at 
NEMC that acts as a cost-accounting mechanism 
integrated with the hospital accounting system. This 
allows comparison of hospital cost data between 
years and between other medical centers. Unlike 
other programs, in which hospital charges are used 
to define resource utilization, this program examines 
true hospital costs. 30 Hospital charges are based on 
a margin above costs and differ if reimbursement is 
only a portion of what is charged. Charges notori- 
ously provide an inexact estimate of cost savings 
because they include a variable markup. 
In summary, hospital costs have been lessened 
significantly over the last several years by means of 
many interventions in the area of pharmacy, radiolo- 
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gy, and length of  stay. The start ing po int  in  cost 
reduction for carotid endarterectomy began with a 
decrease in length of stay to a goal of one day while 
maintaining quality and safety. Selective use of the 
ICU fol lowed with overn ight  observat ion in an 
intermediate care unit. Pharmacy costs were cut with 
use of  aspirin rather than dextran. Outpat ient duplex 
ultrasonography replaced more expensive interven- 
tional imaging techniques. Further decreases there- 
fore have to stem from operat ing room cost and 
time in the operat ing room. Lower ut i l izat ion of  
hospital resources for carotid endarterectomy has 
been achieved over the last 4 years, but operating 
room costs remained a l imiting factor. This situation 
has to be addressed while quality control is main- 
tained. A l though carotid endarterectomy has been 
amenable to these changes, infra inguinal  arterial 
bypass operations remain a challenge. 
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DISCUSSION 
Dr. Hubert  A. Johnson (Lynn, Mass.). We performed 
the same study with a look at community experience. We 
looked at 100 consecutive carotid endartercctomies over a 
9-month period of time. Our reimbursement diagnosis- 
related group for carotid endarterectomies was only about 
$5800. Despite our reduction to 1 postoperative day, the 
hospital still considered this a 2-day admission, and we 
were only ablc to reduce our costs minimally beyond 
$5800. In addition, with peripheral vascular surgery and in 
situ bypass grafts, I found that generally we could only 
reduce our costs by moving the patients to the transitional 
Care units. So, whether the patients were really being dis- 
charged and whcthcr we arc really saving any money is not 
quite clear. Could you comment on this? 
Dr. Sean P. Roddy. We found that operating room 
costs appear to be the main area to pursue with carotid 
surgery. Every other cost has been lessened (ie, pharmacy, 
radiology, and length of stay). Short operating room dura- 
tion would lessen operating room costs. Because regional 
and general anesthesia techniques have no difference in 
morbidity rates, we thought hat perhaps a regional tech- 
nique could be administered in a holding area. About an 
hour of anesthesia time is usually required for induction 
and reemergence from anesthesia, There is also the cost of 
the electroencephalogram (EEG). Given all that, perhaps 
a regional technique would be better and less expensive. 
Bypass surgery is a more difficult problem. The mor- 
bidity rate is the issue, and we have no great answer for 
how to lower morbidity. 
Dr. Kevin J. McBride (Boston, Mass.). I am sure that 
our health maintenance organizations and primary care 
colleagues are looking closely at data like these. The 
Society for Vascular Surgery/International Society for 
Cardiovascular Surgery demarcates the patient for lower 
extremity bypass graft between claudicant and limb sal- 
vage. That indicator in this kind of study does not seem 
specific. I will give you an example that shows that the 
length of stay for a patient with a bypass graft who has rest 
pain may be significantly shorter than the length of stay for 
patients with tissue loss, either gangrene or ulcers, that 
requires "unscheduled operations." In my practice, it is 
anticipated in their treatment plan that the patients will 
have their bypass graft and then return i several days with 
better circulation or they will have their debridement, 
transmetatarsal amputation, or whatever the procedure 
may be. Maybe your data would better enlighten us if you 
could separate those patients with tissue loss and their fur- 
ther operat ions--not as complications but as a natural 
consequence of  treating their disease--versus those 
patients without tissue loss. 
Dr. Roddy. We did look at the percentage of our 
patients who had tissue loss or gangrene, which was about 
64% of patients. We did not separate those patients specif- 
ically for statistical analysis, but I agree that it might add 
strength to the paper. 
Dr. Gary Gibbons (Boston, Mass.). I too would give 
a bit of caution to breaking down your bypass grafts into 
claudication versus more complex foot lesions that will 
undergo multiple procedures. I think there will be a dif- 
ference in how those patients can be managed and how 
better use of transitional care traits can be made, as Dr. 
Johnson said. Your point about operating room costs is 
real, though, because that is truly the most expensive area 
for surgeons. We also have the dilemma of who is going to 
teach residents and fellows in vascular surgery. There is no 
question that the training of residents and fellows will take 
a longer period of time. Although we are trying to ratch- 
et down costs, we still have an obligation to teach these 
residents and fellows. The same applies to anesthesia; these 
doctors also are teaching. We somehow have to address 
that issue for the payers, and that is where your data will 
have a great deal of merit. 
I also would point out that when you look at total cost, 
you have to break it down to variable costs and fixed costs. 
We cannot do anything about the fixed cost unless we 
ratchet down the length of stay to the extent that  unit or 
an intensive care unit can be closed. As physicians, we can 
focus on the costs that we generate with our ordering, 
which we call variable costs. Those are the efforts where we 
can all look at our practice and see where we can do better. 
Dr. John A. Mannick (Boston, Mass.). One point 
about his paper that I think should be indicated is that we 
are looking at an investigation that actually tried to discuss 
cost. Most of the data in the literature is on the basis of 
cost as defined as charges. You nicely showed that cost and 
charges have little to do with one another, which makes 
most of what is written about this subject suspect. How 
secure are you in your new cost retrieval system that oper- 
ating room costs are, in fact, real? It is easy to use the old 
charges routine when talking about operating room costs 
because those personnel have to be there whether their 
time is being used or wasted. Were the operating room 
costs real costs and not somebody's estimation of costs, or, 
in other words, charges? 
Dr~ Roddy. Through the Transition Systems Incorp- 
orated system, we have broken down operating room 
costs into use, resource, and nursing personnel. We added 
those three costs together to give us true operating room 
costs. We are secure that we have actual cost and not 
charge data. 
Dr. George D. LeMaitre (Andover, Mass.). With 
respect to length of stay and bypass grafting, have you dis- 
tinguished the cost of length of stay between open and 
semiclosed techniques for your in situ grafts? 
Dr. Roddy. No, we did not break down our data that 
way. We looked at everything as a whole. 
Dr. Frank W. LoGerfo (Boston, Mass.). This paper 
was excellent and timely. I have a question about the 
EEG. The EEG is expensive, and your results are xcel- 
lent, but, as you know, other people report excellent 
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results without thc EEG. As Dr. Gibbons indicated, we 
have broken down our operating room costs into these 
subfractions. I do believe the costs are actual costs. With 
an EEG, $1000 probably is added to the total cost of the 
patient care. 
Dr. William C. Mackey. We looked at EEG costs. If 
we used an all regional anesthesia program, with a 
decrcase in the amount of shunting and no use of EEG, 
the EEG monitoring component of the cost would drop 
by about $320. We must have cheaper technician costs 
than you do at Beth Israel Deaconess Medical Center 
West, but the cost savings per case would be about $320. 
